August 26, 2026

Radiologists may misidentify AI images

CT and MRI images were harder to distinguish than radiographs and ultrasound, while subspecialty expertise was associated with greater accuracy.

MDSpire News

August 20, 2026

FDA approves garetosmab for adults with FOP

In the phase 3 OPTIMA trial, the 10-mg/kg and 3-mg/kg doses reduced new heterotopic ossification lesions by 90% and 94%, respectively, compared with placebo at 56 weeks.

MDSpire News

August 19, 2026

Is Gout Linked to Achilles Tendon Rupture?

A case report highlighted extensive intratendinous urate deposition and bilateral Achilles tendon rupture, raising awareness of tendon complications in advanced gout.

MDSpire News

July 20, 2026

Tenderness Tracks Ultrasound Findings

Joint tenderness showed broader associations with concurrent ultrasound abnormalities than patient-reported pain among anti-cyclic citrullinated peptide–positive patients without clinical arthritis.

MDSpire News

July 17, 2026

FDA Approves New Iohexol Vials

The approval includes additional 300 mg iodine/mL and 350 mg iodine/mL vial presentations.

MDSpire News

July 16, 2026

MRI-Based Model May Predict Repairability

In a single-center retrospective study, an internally validated model using radiologist-assessed imaging features and clinical data showed moderate discrimination of arthroscopic meniscal repairability.

MDSpire News

July 14, 2026

Oversight May Be Critical in Patient Acceptance of AI in Radiology

A UK survey found that patients supported AI as a clinical tool but wanted physicians to remain responsible for medical decisions.

MDSpire News

June 25, 2026

Medical Oddities: Could GLP-1s Curb Violence?

Five studies, one question: are we overlooking hidden drivers of health?

MDSpire News

June 22, 2026

FDA Clears Olastrocel Trial Expansion

Additional patients with ongoing opioid use are being enrolled as Creative Medical prepares for potential Phase 3 discussions with the FDA.

MDSpire News

June 15, 2026

FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI

The macrocyclic gadolinium-based contrast agent has a recommended dose of 0.01 mmol/kg actual body weight.

MDSpire News